» Articles » PMID: 36455789

Low Aerobic Capacity in McArdle Disease: A Role for Mitochondrial Network Impairment?

Overview
Journal Mol Metab
Specialty Cell Biology
Date 2022 Dec 1
PMID 36455789
Authors
Affiliations
Soon will be listed here.
Abstract

Background: McArdle disease is caused by myophosphorylase deficiency and results in complete inability for muscle glycogen breakdown. A hallmark of this condition is muscle oxidation impairment (e.g., low peak oxygen uptake (VO)), a phenomenon traditionally attributed to reduced glycolytic flux and Krebs cycle anaplerosis. Here we hypothesized an additional role for muscle mitochondrial network alterations associated with massive intracellular glycogen accumulation.

Methods: We analyzed in depth mitochondrial characteristics-content, biogenesis, ultrastructure-and network integrity in skeletal-muscle from McArdle/control mice and two patients. We also determined VO in patients (both sexes, N = 145) and healthy controls (N = 133).

Results: Besides corroborating very poor VO values in patients and impairment in muscle glycolytic flux, we found that, in McArdle muscle: (a) damaged fibers are likely those with a higher mitochondrial and glycogen content, which show major disruption of the three main cytoskeleton components-actin microfilaments, microtubules and intermediate filaments-thereby contributing to mitochondrial network disruption in skeletal muscle fibers; (b) there was an altered subcellular localization of mitochondrial fission/fusion proteins and of the sarcoplasmic reticulum protein calsequestrin-with subsequent alteration in mitochondrial dynamics/function; impairment in mitochondrial content/biogenesis; and (c) several OXPHOS-related complex proteins/activities were also affected.

Conclusions: In McArdle disease, severe muscle oxidative capacity impairment could also be explained by a disruption of the mitochondrial network, at least in those fibers with a higher capacity for glycogen accumulation. Our findings might pave the way for future research addressing the potential involvement of mitochondrial network alterations in the pathophysiology of other glycogenoses.

Citing Articles

Skeletal muscle disorders as risk factors for type 2 diabetes.

Tammineni E, Manno C, Oza G, Figueroa L Mol Cell Endocrinol. 2025; 599:112466.

PMID: 39848431 PMC: 11886953. DOI: 10.1016/j.mce.2025.112466.


Aerobic capacity and muscle proteome: Insights from a mouse model.

Plaza-Florido A, Santos-Lozano A, Lopez-Ortiz S, Galvez B, Arenas J, Martin M Exp Physiol. 2024; 110(2):293-306.

PMID: 39572863 PMC: 11782188. DOI: 10.1113/EP092308.


Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).

Mishra K, Kakhlon O Biomolecules. 2024; 14(9).

PMID: 39334863 PMC: 11430448. DOI: 10.3390/biom14091096.


Dose-response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease.

Valenzuela P, Santalla A, Alejo L, Merlo A, Bustos A, Castellote-Belles L J Sport Health Sci. 2023; 13(3):398-408.

PMID: 38030066 PMC: 11116998. DOI: 10.1016/j.jshs.2023.11.006.

References
1.
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View

2.
Munguia-Izquierdo D, Santalla A, Lucia A . Cardiorespiratory fitness, physical activity, and quality of life in patients with McArdle disease. Med Sci Sports Exerc. 2014; 47(4):799-808. DOI: 10.1249/MSS.0000000000000458. View

3.
Weibel E, Hoppeler H . Exercise-induced maximal metabolic rate scales with muscle aerobic capacity. J Exp Biol. 2005; 208(Pt 9):1635-44. DOI: 10.1242/jeb.01548. View

4.
Lewis S, Haller R . The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. J Appl Physiol (1985). 1986; 61(2):391-401. DOI: 10.1152/jappl.1986.61.2.391. View

5.
Nogales-Gadea G, Rubio J, Fernandez-Cadenas I, Garcia-Consuegra I, Lucia A, Cabello A . Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat. 2007; 29(2):277-83. DOI: 10.1002/humu.20649. View